skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 69,470  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Exploring novel immunotherapy biomarker candidates induced by cancer deformation
Material Type:
Article
Add to My Research

Exploring novel immunotherapy biomarker candidates induced by cancer deformation

PloS one, 2024-05, Vol.19 (5), p.e0303433-e0303433 [Peer Reviewed Journal]

Copyright: © 2024 Kim et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2024 Public Library of Science ;2024 Kim et al 2024 Kim et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0303433 ;PMID: 38743676

Full text available

2
Chaperone-mediated MHC-I peptide exchange in antigen presentation
Material Type:
Article
Add to My Research

Chaperone-mediated MHC-I peptide exchange in antigen presentation

IUCrJ, 2024-05, Vol.11 (Pt 3), p.287-298

open access. ;COPYRIGHT 2024 International Union of Crystallography ;ISSN: 2052-2525 ;EISSN: 2052-2525 ;DOI: 10.1107/S2052252524002768 ;PMID: 38656309

Full text available

3
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy
Material Type:
Article
Add to My Research

Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy

Vaccines (Basel), 2024-05, Vol.12 (5), p.498 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2076-393X ;EISSN: 2076-393X ;DOI: 10.3390/vaccines12050498 ;PMID: 38793749

Full text available

4
Exploring the Potential of the Aryl Hydrocarbon Receptor for Personalized Medicine
Material Type:
magazinearticle
Add to My Research

Exploring the Potential of the Aryl Hydrocarbon Receptor for Personalized Medicine

Drug development & delivery, 2024-04

Copyright Drug Development & Delivery Apr 2024 ;ISSN: 2372-2770 ;EISSN: 2641-7855

Full text available

5
Bioengineering Skin Substitutes for Wound Management-Perspectives and Challenges
Material Type:
Article
Add to My Research

Bioengineering Skin Substitutes for Wound Management-Perspectives and Challenges

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3702 [Peer Reviewed Journal]

COPYRIGHT 2024 MDPI AG ;2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1422-0067 ;ISSN: 1661-6596 ;EISSN: 1422-0067 ;DOI: 10.3390/ijms25073702 ;PMID: 38612513

Full text available

6
Tumor immune evasion: insights from CRISPR screens and future directions
Material Type:
Article
Add to My Research

Tumor immune evasion: insights from CRISPR screens and future directions

The FEBS journal, 2024-04, Vol.291 (7), p.1386-1399 [Peer Reviewed Journal]

2023 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. ;2023 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies. ;2023. This article is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1742-464X ;EISSN: 1742-4658 ;DOI: 10.1111/febs.17003 ;PMID: 37971319

Full text available

7
KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
Material Type:
Article
Add to My Research

KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC

Cell death & disease, 2024-02, Vol.15 (2), p.175-175 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;EISSN: 2041-4889 ;DOI: 10.1038/s41419-024-06563-3 ;PMID: 38413563

Full text available

8
In vivo functional immunoprotection correlates for vaccines against invasive bacteria
Material Type:
Article
Add to My Research

In vivo functional immunoprotection correlates for vaccines against invasive bacteria

Vaccine, 2024-02, Vol.42 (4), p.853-863 [Peer Reviewed Journal]

2024 The Author(s) ;Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved. ;2024. The Author(s) ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2024.01.018 ;PMID: 38233287

Full text available

9
Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer
Material Type:
Article
Add to My Research

Pathological complete response to neoadjuvant chemotherapy may improve antitumor immune response via reduction of regulatory T cells in muscle-invasive bladder cancer

Scientific reports, 2024-01, Vol.14 (1), p.1442-1442, Article 1442 [Peer Reviewed Journal]

2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-51273-7 ;PMID: 38228697

Full text available

10
What if every germ hit you at the exact same time? An immunologist explains
Material Type:
Newspaper Article
Add to My Research

What if every germ hit you at the exact same time? An immunologist explains

The Conversation : Science + Technology, 2024-01-15

2024. This work is published under https://creativecommons.org/licenses/by-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Digital Resources/Online E-Resources

11
What if every germ hit you at the exact same time? An immunologist explains
Material Type:
Newspaper Article
Add to My Research

What if every germ hit you at the exact same time? An immunologist explains

The Conversation : Health, 2024-01-15

2024. This work is published under https://creativecommons.org/licenses/by-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Digital Resources/Online E-Resources

12
Ameliorative effects of Lactobacillus against Aflatoxin B1/ Efeitos beneficos do Lactobacillus contra a Aflatoxin B1
Material Type:
Article
Add to My Research

Ameliorative effects of Lactobacillus against Aflatoxin B1/ Efeitos beneficos do Lactobacillus contra a Aflatoxin B1

Brazilian journal of biology, 2024-01, Vol.84 [Peer Reviewed Journal]

COPYRIGHT 2024 Association of the Brazilian Journal of Biology ;ISSN: 1519-6984 ;EISSN: 1678-4375 ;DOI: 10.1590/1519-6984.250517

Full text available

13
Ameliorative effects of Lactobacillus against Aflatoxin B1
Material Type:
Article
Add to My Research

Ameliorative effects of Lactobacillus against Aflatoxin B1

Brazilian journal of biology, 2024, Vol.84, p.e250517-9 [Peer Reviewed Journal]

2024. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This work is licensed under a Creative Commons Attribution 4.0 International License. ;ISSN: 1519-6984 ;ISSN: 1678-4375 ;EISSN: 1678-4375 ;DOI: 10.1590/1519-6984.250517 ;PMID: 34932626

Full text available

14
Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)
Material Type:
Article
Add to My Research

Investigating chimeric antigen receptor T cell therapy and the potential for cancer immunotherapy (Review)

Molecular and clinical oncology, 2023-12, Vol.19 (6), Article 95

COPYRIGHT 2023 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2023 ;Copyright: © Poojary et al. 2023 ;ISSN: 2049-9450 ;EISSN: 2049-9469 ;DOI: 10.3892/mco.2023.2691

Full text available

15
Oligodendrocyte-derived IL-33 functions as a microglial survival factor during neuroinvasive flavivirus infection
Material Type:
Article
Add to My Research

Oligodendrocyte-derived IL-33 functions as a microglial survival factor during neuroinvasive flavivirus infection

PLoS pathogens, 2023-11, Vol.19 (11), p.e1011350-e1011350 [Peer Reviewed Journal]

Copyright: © 2023 Norris et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;2023 Norris et al 2023 Norris et al ;ISSN: 1553-7374 ;ISSN: 1553-7366 ;EISSN: 1553-7374 ;DOI: 10.1371/journal.ppat.1011350 ;PMID: 37983247

Full text available

16
Efficacy of Interleukin-1[beta] Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis
Material Type:
Article
Add to My Research

Efficacy of Interleukin-1[beta] Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis

Clinical ophthalmology (Auckland, N.Z.), 2023-10, Vol.17, p.2967 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1177-5483 ;EISSN: 1177-5483 ;DOI: 10.2147/OPTH.S419310

Full text available

17
COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract
Material Type:
Article
Add to My Research

COVID-19 Vaccines for Optimizing Immunity in the Upper Respiratory Tract

Viruses, 2023-10, Vol.15 (11), p.2203 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v15112203 ;PMID: 38005881

Full text available

18
Mathematical Model Predicting the Kinetics of Intracellular LCMV Replication
Material Type:
Article
Add to My Research

Mathematical Model Predicting the Kinetics of Intracellular LCMV Replication

Mathematics (Basel), 2023-10, Vol.11 (21), p.4454 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2227-7390 ;EISSN: 2227-7390 ;DOI: 10.3390/math11214454

Full text available

19
Identification and In Silico Characterization of a Conserved Peptide on Influenza Hemagglutinin Protein: A New Potential Antigen for Universal Influenza Vaccine Development
Material Type:
Article
Add to My Research

Identification and In Silico Characterization of a Conserved Peptide on Influenza Hemagglutinin Protein: A New Potential Antigen for Universal Influenza Vaccine Development

Nanomaterials (Basel, Switzerland), 2023-10, Vol.13 (20), p.2796 [Peer Reviewed Journal]

COPYRIGHT 2023 MDPI AG ;2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2079-4991 ;EISSN: 2079-4991 ;DOI: 10.3390/nano13202796 ;PMID: 37887946

Full text available

20
Tuberculosis control by novel vaccines development and Indian initiatives
Material Type:
Article
Add to My Research

Tuberculosis control by novel vaccines development and Indian initiatives

MGM journal of medical sciences, 2023-10, Vol.10 (4), p.762-782 [Peer Reviewed Journal]

ISSN: 2347-7946 ;EISSN: 2347-7962 ;DOI: 10.4103/mgmj.mgmj_241_23

Full text available

Results 1 - 20 of 69,470  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (65,323)

Refine My Results

New Records 

  1. New From Last Month  (3)
  2. New From Last 3 Month  (7)
  3. More options open sub menu

Language 

  1. English  (69,442)
  2. Japanese  (9,021)
  3. French  (22)
  4. German  (11)
  5. Russian  (9)
  6. Portuguese  (6)
  7. Spanish  (3)
  8. Ukrainian  (2)
  9. Latin  (2)
  10. Indonesian  (1)
  11. Norwegian  (1)
  12. Turkish  (1)
  13. Chinese  (1)
  14. More options open sub menu

Searching Remote Databases, Please Wait